Angiodynamics (ANGO) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Angiodynamics (ANGO) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 24.56% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -1.20% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 18.63% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -0.49% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -33.83% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -58.17% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 34.13% |
| 10 | Angiodynamics | 655.49 Mn | 601.62 Mn | 46.77 Mn | 19.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 19.01% |
| Feb 28, 2026 | 5.19% |
| Nov 30, 2025 | 9.21% |
| Aug 31, 2025 | 5.70% |
| May 31, 2025 | 1.16% |
| Feb 28, 2025 | 3.85% |
| Nov 30, 2024 | -8.74% |
| Aug 31, 2024 | -22.44% |
| May 31, 2024 | 11.60% |
| Feb 29, 2024 | -275.56% |
| Nov 30, 2023 | -89.51% |
| Aug 31, 2023 | 133.62% |
| May 31, 2022 | -28.29% |
| Feb 28, 2022 | -42.89% |
| Nov 30, 2021 | -51.22% |
| Aug 31, 2021 | -49.36% |
| May 31, 2021 | -61.46% |
| Feb 28, 2021 | -41.96% |
| Nov 30, 2020 | -42.86% |
| Aug 31, 2020 | -41.92% |